DeepMed Research

Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

Active, not recruiting

Conditions: Stage IA Non-small Cell Lung Cancer

Interventions: Procedure: Extent of pulmonary resection

First Posted Date: 2017-02-28

Last Posted Date: 2023-12-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1018

Registration Number: NCT03066297

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma

Phase 2

Conditions: High Risk Neuroblastoma

Interventions: Drug: Cyclophosphamide
Drug: Carboplatin
Drug: Etoposide
Radiation: 131I-MIBG
Drug: Thiotepa
Drug: Melphalan

First Posted Date: 2017-02-23

Last Posted Date: 2018-09-18

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT03061656

A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder

Phase 2

Conditions: Urinary Bladder

Interventions: Drug: Gemcitabine
Drug: Cisplatin

First Posted Date: 2017-02-23

Last Posted Date: 2022-03-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 49

Registration Number: NCT03061630

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

Phase 2

Terminated

Conditions: Stomach Neoplasms

Interventions: Drug: AZD2014

First Posted Date: 2017-02-23

Last Posted Date: 2019-05-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1

Registration Number: NCT03061708

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma

Phase 2

Conditions: Prostatic Neoplasm

Interventions: Drug: Docetaxel
Other: Androgen-Deprivation Therapy (ADT)

First Posted Date: 2017-02-23

Last Posted Date: 2022-03-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 42

Registration Number: NCT03061643

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients

Phase 2

Conditions: Stage IIIA Non-small Cell Lung Cancer

Interventions: Drug: Pembrolizumab
Procedure: Curative resection
Procedure: Neoadjuvant concurrent chemoradiotherapy
Drug: Cisplatin
Drug: Paclitaxel

First Posted Date: 2017-02-15

Last Posted Date: 2017-02-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 37

Registration Number: NCT03053856

Locations: 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression

Phase 2

Completed

Conditions: Stomach Neoplasms

Interventions: Drug: Vismodegib 150 mg

First Posted Date: 2017-02-14

Last Posted Date: 2021-06-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 10

Registration Number: NCT03052478

Locations: 🇰🇷
Samsung Medical Center, Seoul City, Seoul, Korea, Republic of

A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI

Phase 2

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Cisplatin
Drug: Pemetrexed

First Posted Date: 2017-02-10

Last Posted Date: 2017-02-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 96

Registration Number: NCT03050437

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults

Not Applicable

Completed

Conditions: Healthy
Stroke

Interventions: Procedure: Gait, sit-to-stand movement, stair climbing and treadmill gait
Procedure: Sit-to-stand movement and treadmill gait
Device: gait enhancing mechatronic system (GEMS)
Device: treadmill

First Posted Date: 2017-02-09

Last Posted Date: 2019-04-29

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT03048968

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill Patients

Not Applicable

Conditions: ICU Patients

Interventions: Diagnostic Test: kidney function assessment by creatinine based eGFR
Diagnostic Test: kidney function assessment by 4 hour creatinine clearance

First Posted Date: 2017-02-07

Last Posted Date: 2017-02-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 172

Registration Number: NCT03045692

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy